Skip to main content
. 2020 Nov 10;21(22):8447. doi: 10.3390/ijms21228447
ADT Androgen deprivation therapy
AR Androgen receptor
AREs Androgen- Responsive Elements
ATM Ataxia-telangectasia mutated
CRPC Castration-resistant prostate cancer
DDR DNA damage repair
DHT dihydrotestosterone
DSBs Double strand breaks
HR Homologous recombination
HRE Hypoxia-Responsive Element
HFRT hypofractionated radiotherapy
e-HFRT Extreme hypofractionated radiotherapy
m-HFRT Moderate hypofractionated radiotherapy
PCa Prostate cancer
SASP Senescence-associated secretory phenotype
SD Standard deviation
PET positron emission tomography